The EoE Cancer Alliance are supporting the implementation of the Faster Diagnosis Standards (FDS) performance for cancer to ensure patients who are referred for suspected cancer have a timely diagnosis.
The standard will ensure patients will be diagnosed or have cancer ruled out within 28 days of being referred for suspected cancer. For patients who are diagnosed with cancer, it means their treatment can begin as soon as possible. For those who are not, they can have their minds put at rest more quickly.
The Faster Diagnosis Programme aims to deliver:
- An earlier and faster diagnosis for patients, whether or not they are ultimately diagnosed with cancer.
- Excellent patient experience; a holistic assessment of patient needs and streamlined care.
- Increased capacity in the system through more efficient diagnostic pathways.
The faster diagnosis programme covers:
- The development of Non-Specific Symptom pathways (NSS).
- Improving existing pathways in line with the published Best Practice Timed Pathway (BPTP) guidance.
Guidance has been published by NHS England on how diagnosis within 28-days can be achieved for the suspected cancer pathway, this is available on the national guidance page - NHS England » Rapid cancer diagnostic and assessment pathways .
EoE Cancer Alliance Projects
We are working across multiple programmes to deliver the Faster Diagnosis Standard (FDS) through workstreams such as NSS, BPTP, core pathway improvements, local pathway innovations, diagnostic capacity.
- Development of data and dashboards to better understand patients pathways
- System level approach to recovery of cancer services
- Sharing best practice exemplars across the region
- Linking with diagnostics
Skin cancer is the most common cancer in England . In 2019/20 there were 3 million outpatient appointments in dermatology in England in the year to April 2022 and dermatology services receive more urgent referrals for suspected cancer than any other speciality .
During 2022/23, Eastern AHSN (Academic Health Science Network) were commissioned to carry out an independent review of how teledermatology platforms have been implemented and used in the East of England to date. An independent baseline review was also conducted with Integrated Care Systems.
What is Teledermatology?
Teledermatology refers to the use of static digital images to triage, diagnose, monitor or assess skin conditions without the patient being physically present, to exchange medical information. Teledermatology services cross-systems can support service transformation, elective recovery, access to high quality care and reduce waiting times.
To collate information on the various teledermatology platforms, technologies and service models in place in order to support considerations for planning, development and commissioning of teledermatology services in the East of England.
Our collaboration with the East of England Cancer Alliances produced a review of teledermatology pathways in the East of England, including considerations for planning and commissioning. The reviews findings consider improvements of system efficiencies and cost effectiveness. It also offers a series of recommendations around staff experience, patient experience, health outcomes and health inequalities.
Read the project’s summary report
The infographic linked in this section provides considerations for the planning and commissioning of teledermatology platforms in the East of England. The infographic should be read in conjunction with the project summary report (linked above).
 NHS Teledermatology Roadmap – outpatient recovery and transformation platform. June 2023 [accessed 3 July 2023]
NHS England teledermatology roadmap
Access NHS England’s updated teledermatology roadmap:
For more information please contact email@example.com